Sagimet Biosciences
€4.36
37
-€0.04-0.91% Tuesday 07:55
Statistics
Day High
4.36
Day Low
4.36
52W High
8.75
52W Low
1.71
Volume
-
Avg. Volume
-
Mkt Cap
135.16M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
20MayExpected
Expected EPS
-0.31570164
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-86.52MNet Income
Analyst Ratings
$19.43Average Price Target
The highest estimate is 26.56.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 60%
Hold 40%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow 0O2.F. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Viking Therapeutics
VKTX
Mkt Cap4.02B
Madrigal Pharmaceuticals
MDGL
Mkt Cap12.55B
Galmed Pharmaceuticals
GLMD
Mkt Cap3.55M
Gilead Sciences
GILD
Mkt Cap173.41B
Agios Pharmaceuticals
AGIO
Mkt Cap2.06B
About
Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. Its lead drug candidate is Denifanstat, a FASN inhibitor for the treatment of nonalcoholic steatohepatitis and acne. The company is also developing TVB-3567, a FASN inhibitor for the treatment of various types of cancers. The company was formerly known as 3-V Biosciences, Inc. and changed its name to Sagimet Biosciences Inc. in August 2019. Sagimet Biosciences Inc. was incorporated in 2006 and is headquartered in San Mateo, California.
Show more...
CEO
Mr. David A. Happel
Employees
16
Country
DE
ISIN
US7867001049
WKN
000A3CPAM
Listings
0 Comments
Share your thoughts
FAQ
What is Sagimet Biosciences stock price today?▼
The current price of 0O2.F is €4.36 EUR — it has decreased by -0.91% in the past 24 hours. Watch Sagimet Biosciences stock price performance more closely on the chart.
What is Sagimet Biosciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Sagimet Biosciences stocks are traded under the ticker 0O2.F.
Is Sagimet Biosciences stock price growing?▼
0O2.F stock has fallen by -1.8% compared to the previous week, the month change is a -5.22% fall, over the last year Sagimet Biosciences has showed a +142.22% increase.
What is Sagimet Biosciences market cap?▼
Today Sagimet Biosciences has the market capitalization of 135.16M
When is the next Sagimet Biosciences earnings date?▼
Sagimet Biosciences is going to release the next earnings report on May 20, 2026.
What were Sagimet Biosciences earnings last quarter?▼
0O2.F earnings for the last quarter are -0.25 EUR per share, whereas the estimation was -0.37 EUR resulting in a +32.9% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Sagimet Biosciences revenue for the last year?▼
Sagimet Biosciences revenue for the last year amounts to 0 EUR.
What is Sagimet Biosciences net income for the last year?▼
0O2.F net income for the last year is -86.52M EUR.
How many employees does Sagimet Biosciences have?▼
As of April 08, 2026, the company has 16 employees.
When did Sagimet Biosciences complete a stock split?▼
Sagimet Biosciences has not had any recent stock splits.
Where is Sagimet Biosciences headquartered?▼
Sagimet Biosciences is headquartered in San Mateo, DE.